
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT
- About


Clover Health Investments Corp (CLOV)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/02/2025: CLOV (5-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $3.65
1 Year Target Price $3.65
2 | Strong Buy |
0 | Buy |
2 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 226.47% | Avg. Invested days 39 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.34B USD | Price to earnings Ratio - | 1Y Target Price 3.65 |
Price to earnings Ratio - | 1Y Target Price 3.65 | ||
Volume (30-day avg) 4 | Beta 1.92 | 52 Weeks Range 2.12 - 4.87 | Updated Date 09/2/2025 |
52 Weeks Range 2.12 - 4.87 | Updated Date 09/2/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.08 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-08-04 | When Before Market | Estimate -0.0187 | Actual 0.0329 |
Profitability
Profit Margin -2.68% | Operating Margin (TTM) -2.21% |
Management Effectiveness
Return on Assets (TTM) -4.26% | Return on Equity (TTM) -12.59% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 1013396883 | Price to Sales(TTM) 0.84 |
Enterprise Value 1013396883 | Price to Sales(TTM) 0.84 | ||
Enterprise Value to Revenue 0.63 | Enterprise Value to EBITDA -0.65 | Shares Outstanding 420139008 | Shares Floating 400287678 |
Shares Outstanding 420139008 | Shares Floating 400287678 | ||
Percent Insiders 3.88 | Percent Institutions 35.16 |
Upturn AI SWOT
Clover Health Investments Corp

Company Overview
History and Background
Clover Health Investments Corp. was founded in 2014. It went public in 2021 via a SPAC merger with Social Capital Hedosophia Holdings Corp. III. Clover Health aims to use its Clover Assistant platform to improve healthcare outcomes for Medicare Advantage members.
Core Business Areas
- Medicare Advantage Plans: Clover Health offers Medicare Advantage plans to eligible beneficiaries. These plans provide comprehensive healthcare coverage, including medical, hospital, and prescription drug benefits.
- Clover Assistant: Clover Assistant is a software platform designed to provide physicians with real-time data and insights at the point of care. It helps doctors make more informed decisions, manage patient care more effectively, and improve overall health outcomes.
Leadership and Structure
Andrew Toy is the Chief Executive Officer. The company has a board of directors overseeing strategic direction and governance.
Top Products and Market Share
Key Offerings
- Medicare Advantage Plans: Clover Health's core product is its Medicare Advantage plans. These plans are offered to eligible Medicare beneficiaries. Market share data for specific regions fluctuates and is dependent on competition. Competitors include UnitedHealth Group (UNH), Humana (HUM), and CVS Health (CVS).
- Clover Assistant: Clover Assistant is a SaaS platform. While it does generate revenue, its primary value is in improving healthcare outcomes and efficiency within the Clover Health ecosystem. Precise revenue figures are difficult to extract as it's integral to the MA business. Competitors are the other AI-driven software platforms by its main competitors.
Market Dynamics
Industry Overview
The healthcare industry, particularly the Medicare Advantage market, is experiencing growth due to the aging population and increasing demand for value-based care. It is also highly competitive with a lot of regulatory oversight.
Positioning
Clover Health aims to differentiate itself by leveraging technology, specifically the Clover Assistant, to improve care coordination and reduce costs. Its competitive advantage lies in its data-driven approach and focus on physician enablement.
Total Addressable Market (TAM)
The TAM for Medicare Advantage is significant, projected to be in the hundreds of billions of dollars. Clover Health is positioned to capture a share of this market through its technology-driven approach and focus on underserved populations.
Upturn SWOT Analysis
Strengths
- Proprietary technology (Clover Assistant)
- Focus on data-driven healthcare
- Growth in membership
- Focus on value-based care
Weaknesses
- High medical costs
- Dependence on government regulations
- Relatively small market share compared to larger competitors
- History of negative profitability
Opportunities
- Expansion into new geographic markets
- Increased adoption of Clover Assistant by physicians
- Partnerships with healthcare providers
- Further penetration of the Medicare Advantage market
Threats
- Increased competition from larger, established players
- Changes in government regulations affecting Medicare Advantage
- Rising healthcare costs
- Adverse selection in risk pools
Competitors and Market Share
Key Competitors
- UNH
- HUM
- CVS
Competitive Landscape
Clover Health competes with larger, well-established players in the Medicare Advantage market. Its advantage lies in its technology and focus on physician enablement, but it faces challenges in scaling and achieving profitability.
Growth Trajectory and Initiatives
Historical Growth: Clover Health has experienced significant membership growth but has faced challenges with profitability.
Future Projections: Future growth is expected to be driven by increased adoption of Medicare Advantage plans and expansion into new markets. Analyst estimates vary widely based on the company's ability to achieve profitability.
Recent Initiatives: Recent initiatives include expanding Clover Assistant functionality, improving care coordination, and focusing on cost management.
Summary
Clover Health is a growth-oriented company seeking to disrupt the Medicare Advantage market with its technology platform. While it has shown impressive membership growth, it is struggling to become profitable. The company will need to efficiently manage medical costs and differentiate itself from competitors to thrive.
Peer Comparison
Sources and Disclaimers
Data Sources:
- SEC filings
- Investor presentations
- Analyst reports
- Company press releases
Disclaimers:
The information provided is for informational purposes only and should not be considered investment advice. Market share data is approximate and may vary based on source and methodology. Financial data is based on publicly available information and may not be exhaustive.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Clover Health Investments Corp
Exchange NASDAQ | Headquaters Wilmington, DE, United States | ||
IPO Launch date 2001-01-02 | Co-Founder, CEO & Director Mr. Andrew Toy | ||
Sector Healthcare | Industry Healthcare Plans | Full time employees 570 | Website https://www.cloverhealth.com |
Full time employees 570 | Website https://www.cloverhealth.com |
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It operates Clover Assistant, a software platform to execute strategy by enabling physicians to detect, identify, and manage chronic diseases earlier than they otherwise could. The company is based in Wilmington, Delaware.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.